Systemic Embolism clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

    “Volunteer for research and contribute to discoveries that may improve heart health for you, your family, and your community!”

    open to eligible people ages 18 years and up

    The purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) device as compared to the commercially available LAAC devices in participants with non-valvular atrial fibrillation (NVAF) to reduce the risk of stroke (blocked blood vessel or bleeding in brain) and systemic embolism (blockage in a blood vessel harming vital organs).

    Rancho Cordova, California and other locations

Last updated: